tiprankstipranks
Trending News
More News >
Matinas BioPharma (MTNB)
:MTNB

Matinas BioPharma (MTNB) Revenue

Compare
1,526 Followers

Matinas BioPharma Revenue

Matinas BioPharma had a revenue of 0.00 in the quarter ending Mar 31, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 962.00K, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Matinas BioPharma had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
962.00K
Revenue Growth
-100.00%
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
3
Market Cap
$4.44M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
0.00-1.10M-100.00%
Dec 31, 2023
1.10M-2.09M-65.62%
Dec 31, 2022
3.19M3.15M+9,464.10%
Dec 31, 2021
33.33K-125.00K-78.95%
Dec 31, 2020
158.33K68.33K+75.93%
Dec 31, 2019
90.00K-29.75K-24.84%
Dec 31, 2018
119.75K-29.94K-20.00%
Dec 31, 2017
149.69K+∞%
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis